Line 110: | Line 110: | ||
#menu2 li:nth-child(5){ | #menu2 li:nth-child(5){ | ||
− | background-color: #FFFFFF; | + | background-color:#FFFFFF; |
} | } | ||
Line 133: | Line 133: | ||
} | } | ||
− | |||
#menu2 li:nth-child(5) li{ | #menu2 li:nth-child(5) li{ | ||
background:#00CED1; | background:#00CED1; | ||
Line 303: | Line 302: | ||
display: block; | display: block; | ||
} | } | ||
− | |||
Line 335: | Line 333: | ||
<li><a href=" https://2016.igem.org/Team:Pasteur_Paris/AboutUs "><center><img src="https://static.igem.org/mediawiki/2016/9/90/Logo_team_pasteur.png" height="40px" width="40px"></center><b></b><FONT size ="3pt"color=#8B8378><br>About us</br></FONT></a > | <li><a href=" https://2016.igem.org/Team:Pasteur_Paris/AboutUs "><center><img src="https://static.igem.org/mediawiki/2016/9/90/Logo_team_pasteur.png" height="40px" width="40px"></center><b></b><FONT size ="3pt"color=#8B8378><br>About us</br></FONT></a > | ||
<ul> | <ul> | ||
− | <li><a href=" https://2016.igem.org/Team:Pasteur_Paris/AboutUs " href | + | <li><a href=" https://2016.igem.org/Team:Pasteur_Paris/AboutUs " href "#about us">Our team</a></li> |
<li><a href="https://2016.igem.org/Team:Pasteur_Paris/AboutUs">Attribution</a></li> | <li><a href="https://2016.igem.org/Team:Pasteur_Paris/AboutUs">Attribution</a></li> | ||
<li><a href="https://2016.igem.org/Team:Pasteur_Paris/AboutUs">Sponsors</a></li> | <li><a href="https://2016.igem.org/Team:Pasteur_Paris/AboutUs">Sponsors</a></li> | ||
Line 352: | Line 350: | ||
<ul> | <ul> | ||
<li><a href="https://2016.igem.org/Team:Pasteur_Paris/Science ">Protocols</a></li> | <li><a href="https://2016.igem.org/Team:Pasteur_Paris/Science ">Protocols</a></li> | ||
− | <li><a href="https://2016.igem.org/Team:Pasteur_Paris/ | + | <li><a href="https://2016.igem.org/Team:Pasteur_Paris/Notebook ">Notebook</a></li> |
<li><a href="https://2016.igem.org/Team:Pasteur_Paris/Results ">Results</a></li> | <li><a href="https://2016.igem.org/Team:Pasteur_Paris/Results ">Results</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
− | |||
<li><a href=" https://2016.igem.org/Team:Pasteur_Paris/HumanPractice "><center><img src="https://static.igem.org/mediawiki/2016/f/f5/HP.png " height="40px" width="40px"><b></b><FONT size ="3pt" color=#8B8378></center><br>Human Practice</br></FONT></a> | <li><a href=" https://2016.igem.org/Team:Pasteur_Paris/HumanPractice "><center><img src="https://static.igem.org/mediawiki/2016/f/f5/HP.png " height="40px" width="40px"><b></b><FONT size ="3pt" color=#8B8378></center><br>Human Practice</br></FONT></a> | ||
<ul> | <ul> | ||
− | <li><a href="https://2016.igem.org/Team:Pasteur_Paris/ | + | <li><a href="https://2016.igem.org/Team:Pasteur_Paris/law"> Law</a></li> |
− | <li><a href="https://2016.igem.org/Team:Pasteur_Paris/ | + | <li><a href="https://2016.igem.org/Team:Pasteur_Paris/Outreach">Outreach</a></li> |
− | <li><a href="https://2016.igem.org/Team:Pasteur_Paris/ | + | <li><a href="https://2016.igem.org/Team:Pasteur_Paris/Collaborations"> Collaborations</a></li> |
<li><a href="https://2016.igem.org/Team:Pasteur_Paris/Events"> Events</a></li> | <li><a href="https://2016.igem.org/Team:Pasteur_Paris/Events"> Events</a></li> | ||
</ul> | </ul> |
Revision as of 10:09, 23 August 2016
Vector-borne (re) emerging diseases are responsible for severe epidemics worldwide. In most cases, vaccines or treatments are not available, and insecticides are the primary source for vector control.
Consequently, over spraying of insecticides impacts the environment and leads to the selection of insecticide resistant mosquitoes.
Therefore, we developed a novel diagnostic device, Mos(kit)o that includes a fixed or mobile mosquito trap and a biosilica cellulose composite patch from genetically modified Escherichia coli.
The design of the patch creates a multilayered matrix coated with antibodies capable of detecting a wide panel of vector-borne pathogens and insecticide resistant proteins from captured mosquitoes.
Additionally, the patch will have 2D barcoded readouts, generating an environmental surveillance database. A precise map of vector hot spots will provide a better assessment and response to vector-borne diseases, assisting local health authorities with anticipating and preparing for an epidemic. Our tool will be user-friendly, safe, and applicable.
Our Abstract!